dc.contributor.author | Elliott, Marguerite | eng |
dc.contributor.author | Couchene, Elizabeth | eng |
dc.contributor.author | Luft, Diane Davis | eng |
dc.date.issued | 2007 | eng |
dc.description.abstract | Only high-risk close contacts of known cases should receive prophylactic antibiotics, according to the Centers for Disease Control and Prevention (CDC). The CDC defines high-risk as (1) infants who are <12 months, (2) those especially vulnerable to the complications of pertussis, or (3) those, such as health care workers, in close contact with high-risk individuals (strength of recommendation [SOR]: C, based on consensus/expert opinion). Evidence is insufficient to support a benefit of prophylactic antibiotic treatment for all household pertussis contacts to prevent the development or spread of illness (SOR: B, based on a systematic review of studies). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3687 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2007 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 56, no. 05 (May 2007): 399-400 | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | antibiotics | eng |
dc.subject | high-risk individuals | eng |
dc.subject | infants | eng |
dc.subject.lcsh | Bordetella pertussis -- Prevention | eng |
dc.subject.lcsh | Erythromycin -- Therapeutic use | eng |
dc.subject.lcsh | Pertussis vaccines | eng |
dc.title | Which patients with suspected exposure to pertussis should receive prophylaxis? | eng |
dc.type | Article | eng |